These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 11860617)

  • 1. Structural model of nicotinic acetylcholine receptor isotypes bound to acetylcholine and nicotine.
    Schapira M; Abagyan R; Totrov M
    BMC Struct Biol; 2002; 2():1. PubMed ID: 11860617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular modeling of human pentameric alpha(7) neuronal nicotinic acetylcholine receptor and its interaction with its agonist and competitive antagonist.
    Parthiban M; Rajasekaran MB; Ramakumar S; Shanmughavel P
    J Biomol Struct Dyn; 2009 Apr; 26(5):535-47. PubMed ID: 19236104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A triad of residues is functionally transferrable between 5-HT
    Mosesso R; Dougherty DA
    J Biol Chem; 2018 Feb; 293(8):2903-2914. PubMed ID: 29298898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring the nature of molecular recognition in nicotinic acetylcholine receptors.
    Schmitt JD
    Curr Med Chem; 2000 Aug; 7(8):749-800. PubMed ID: 10828287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural characterization of binding mode of smoking cessation drugs to nicotinic acetylcholine receptors through study of ligand complexes with acetylcholine-binding protein.
    Rucktooa P; Haseler CA; van Elk R; Smit AB; Gallagher T; Sixma TK
    J Biol Chem; 2012 Jul; 287(28):23283-93. PubMed ID: 22553201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rational understanding of nicotinic receptors drug binding.
    Grutter T; Le Novère N; Changeux JP
    Curr Top Med Chem; 2004; 4(6):645-50. PubMed ID: 14965300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling subtype-selective agonists binding with alpha4beta2 and alpha7 nicotinic acetylcholine receptors: effects of local binding and long-range electrostatic interactions.
    Huang X; Zheng F; Chen X; Crooks PA; Dwoskin LP; Zhan CG
    J Med Chem; 2006 Dec; 49(26):7661-74. PubMed ID: 17181149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insight in nAChR subtype selectivity from AChBP crystal structures.
    Rucktooa P; Smit AB; Sixma TK
    Biochem Pharmacol; 2009 Oct; 78(7):777-87. PubMed ID: 19576182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ligand selectivity for the acetylcholine binding site of the rat alpha4beta2 and alpha3beta4 nicotinic subtypes investigated by molecular docking.
    Bisson WH; Scapozza L; Westera G; Mu L; Schubiger PA
    J Med Chem; 2005 Aug; 48(16):5123-30. PubMed ID: 16078832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AChBP-targeted alpha-conotoxin correlates distinct binding orientations with nAChR subtype selectivity.
    Dutertre S; Ulens C; Büttner R; Fish A; van Elk R; Kendel Y; Hopping G; Alewood PF; Schroeder C; Nicke A; Smit AB; Sixma TK; Lewis RJ
    EMBO J; 2007 Aug; 26(16):3858-67. PubMed ID: 17660751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystal structure of an ACh-binding protein reveals the ligand-binding domain of nicotinic receptors.
    Brejc K; van Dijk WJ; Klaassen RV; Schuurmans M; van Der Oost J; Smit AB; Sixma TK
    Nature; 2001 May; 411(6835):269-76. PubMed ID: 11357122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A model for short alpha-neurotoxin bound to nicotinic acetylcholine receptor from Torpedo californica: comparison with long-chain alpha-neurotoxins and alpha-conotoxins.
    Mordvintsev DY; Polyak YL; Levtsova OV; Tourleigh YV; Kasheverov IE; Shaitan KV; Utkin YN; Tsetlin VI
    Comput Biol Chem; 2005 Dec; 29(6):398-411. PubMed ID: 16290328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple interaction regions in the orthosteric ligand binding domain of the α7 neuronal nicotinic acetylcholine receptor.
    Xiao Y; Hammond PS; Mazurov AA; Yohannes D
    J Chem Inf Model; 2012 Nov; 52(11):3064-73. PubMed ID: 23092444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Review on the Receptor-ligand Molecular Interactions in the Nicotinic Receptor Signaling Systems.
    Liu W; Su K
    Pak J Biol Sci; 2018; 21(2):51-66. PubMed ID: 30221881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Galanthamine and non-competitive inhibitor binding to ACh-binding protein: evidence for a binding site on non-alpha-subunit interfaces of heteromeric neuronal nicotinic receptors.
    Hansen SB; Taylor P
    J Mol Biol; 2007 Jun; 369(4):895-901. PubMed ID: 17481657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electrostatic Contributions to the Binding Free Energy of Nicotine to the Acetylcholine Binding Protein.
    Li Z; Chan KC; Nickels JD; Cheng X
    J Phys Chem B; 2022 Nov; 126(43):8669-8679. PubMed ID: 36260486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ligand-receptor interaction at the neural nicotinic acetylcholine binding site: a theoretical model.
    Morreale A; Maseras F; Iriepa I; Gálvez E
    J Mol Graph Model; 2002 Oct; 21(2):111-8. PubMed ID: 12398342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defining the determinants of nicotine selectivity.
    Taylor P
    Proc Natl Acad Sci U S A; 2010 Jul; 107(30):13195-6. PubMed ID: 20643924
    [No Abstract]   [Full Text] [Related]  

  • 19. Computational approaches to understand alpha-conotoxin interactions at neuronal nicotinic receptors.
    Dutertre S; Lewis RJ
    Eur J Biochem; 2004 Jun; 271(12):2327-34. PubMed ID: 15182348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and expression of human alpha7 nicotinic acetylcholine receptor extracellular domain mutants with enhanced solubility and ligand-binding properties.
    Zouridakis M; Zisimopoulou P; Eliopoulos E; Poulas K; Tzartos SJ
    Biochim Biophys Acta; 2009 Feb; 1794(2):355-66. PubMed ID: 19059502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.